| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 09/25/2003 | US20030180845 A nucleic acid sequence encoding the extracellular domain of the polypeptide, lacking its associated signal peptide |
| 09/25/2003 | US20030180844 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180843 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180842 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180841 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180840 A nucleic acid sequence encoding the extracellular domain of the polypeptide, lacking its associated signal peptide |
| 09/25/2003 | US20030180839 A nucleic acid sequence encoding the extracellular domain of the polypeptide, lacking its associated signal peptide |
| 09/25/2003 | US20030180838 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180837 A nucleic acid sequence encoding the extracellular domain of the polypeptide, lacking its associated signal peptide |
| 09/25/2003 | US20030180795 Monoclonal/humanized antibodies; fusion proteins; PRO polypeptides |
| 09/25/2003 | US20030180794 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/25/2003 | US20030180793 Monoclonal/humanized antibodies; fusion proteins; PRO polypeptides |
| 09/25/2003 | US20030180742 A polypetide; catalyzes the hydrolysis of epoxides and arene oxides to their corresponding diols |
| 09/25/2003 | US20030180734 Peptide nucleic acids |
| 09/25/2003 | US20030180286 Antiinflammatory agents; antitumor agents; vascular leakage; hypotensive agents; using nucleic acids |
| 09/25/2003 | US20030180253 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 09/25/2003 | US20030180225 Walnut and ryegrass allergens |
| 09/25/2003 | US20030178368 Charged filtration membranes and uses therefor |
| 09/25/2003 | CA2479355A1 Polymer supported reagents for natural products purification |
| 09/24/2003 | EP1345968A2 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 09/24/2003 | EP1345963A2 Isolation of purified tgf- 1 and tgf- 2 from bone tissue |
| 09/24/2003 | EP1345956A2 Intracellular delivery of biological effectors by novel transporter peptide sequences |
| 09/24/2003 | EP1345955A2 Lactam dipeptide and its use in inhibiting beta-amyloid peptide release |
| 09/24/2003 | EP1345695A2 A method for mixed mode adsorption and mixed mode adsorbents |
| 09/24/2003 | EP1345694A2 A method for the manufacture of compositions containing low concentrations of salts |
| 09/24/2003 | EP1345666A1 Extracorporeal capturing of specific bio-macromolecular entities from extracellular body fluids |
| 09/24/2003 | EP1206482B1 Method for coupling, in solution, a peptide with at least another compound and uses thereof |
| 09/24/2003 | EP0975671B1 Method of chromatographically purifying or fractionating von willebrand factor from a vwf-containing starter material |
| 09/24/2003 | EP0847278B1 Analogs of parathyroid hormone |
| 09/24/2003 | EP0833847B1 Crystals of fragments of cd40 ligand and their use |
| 09/24/2003 | EP0827611B1 Hierarchical biological modelling system and method |
| 09/24/2003 | EP0764048B1 Chromatography adsorbents utilizing mercapto heterocyclic ligands |
| 09/24/2003 | EP0655135B1 Random generation and bio-specific selection of chemical compounds |
| 09/23/2003 | US6624140 Synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome |
| 09/23/2003 | US6623942 Nucleotide sequences coding polypetide for use in treatment of hematopoietic and immunological disorders; wound healing agents |
| 09/23/2003 | US6623938 Human I-FLICE (Inhibitor of FLICE (FADD-like ICE)) polynucleotides; vectors, host cells and recombinant methods for producing the same |
| 09/23/2003 | US6623926 Methods for producing 5′-nucleic acid-protein conjugates |
| 09/23/2003 | US6623655 Nitrilotriacetic acid derivatives; improved specificity and stability; protein purification, detection and/or binding |
| 09/23/2003 | CA2147482C Process for manufacturing crystals of growth hormone and crystals thereby obtained |
| 09/23/2003 | CA2139632C Assay for chagas' disease and reagents for its use |
| 09/18/2003 | WO2003077159A1 Method of forming molecule function network |
| 09/18/2003 | WO2003076936A1 Method of preparing a protein array based on biochemical protein-protein interaction |
| 09/18/2003 | WO2003076898A2 Mycobacterial diagnostics |
| 09/18/2003 | WO2003076456A2 Hepatitis c virus replicon containing a reporter gene and a selectable marker gene |
| 09/18/2003 | WO2003057163A3 Methods for preparing immunoconjugates |
| 09/18/2003 | WO2002072614A3 Algorithmic design of peptides for binding and/or modulation of the functions of receptors and/or other proteins |
| 09/18/2003 | WO2002068455A3 Efficient recovery of correctly refolded proteins |
| 09/18/2003 | WO2002031181A3 Flea synaptic vesicle nucleic acid molecules, proteins and uses thereof |
| 09/18/2003 | US20030176656 Algorithmic design of peptides for binding and/or modulation of the functions of receptors and/or other proteins |
| 09/18/2003 | US20030176651 Multiprotein-complex comprising a nmda receptor and uses thereof |
| 09/18/2003 | US20030176647 Antibodies to OCIF-binding molecules |
| 09/18/2003 | US20030176398 Prodrugs of GABA analogs, compositions and uses thereof |
| 09/18/2003 | US20030176333 Contacting the compound with a CASPR3 polypeptide, polypeptide encoded by a nucleic acid that hybridizes under stringent conditions to a nucleic acid encoding a polypeptide; determining functional effect of the compound upon the CASPR3 |
| 09/18/2003 | US20030175919 ITI-D1 Kunitz domain mutants as hNE inhibitors |
| 09/18/2003 | US20030175880 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/18/2003 | US20030175879 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/18/2003 | US20030175878 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/18/2003 | US20030175877 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175875 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175874 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/18/2003 | US20030175873 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175872 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175871 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175870 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175869 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175868 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175867 PRO polypepetides; antibodies thereto; used in detecting tumors, cell differentiation, proliferation, and for diabetes |
| 09/18/2003 | US20030175866 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/18/2003 | US20030175865 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/18/2003 | US20030175804 Macromolecule detection |
| 09/18/2003 | US20030175799 Comprises stable amino acid sequence scaffold which mimics native protein structures and interactions; drug screening and design |
| 09/18/2003 | US20030175725 Mycobacterial diagnostics |
| 09/18/2003 | US20030175691 Method for isolating proteins or protein and nucleic acid associations, or particle and protein complexes, reagent and uses |
| 09/18/2003 | US20030175311 A protein encoded by DNA sequence, for protecting poultry; veterinary medicine |
| 09/18/2003 | US20030175285 Major histocompatibility complex ligands, comprising proteins, peptides, epitopes, polypeptides, mimetics or lipopeptides, used as vaccines |
| 09/18/2003 | US20030175238 Chemokine conjugates |
| 09/18/2003 | CA2478963A1 Method of generating molecule-function network |
| 09/17/2003 | EP1344826A1 Materials comprising and methods of preparation and use for ribosome - inactivating proteins |
| 09/17/2003 | EP1344060A2 Process for determining target function and identifying drug leads |
| 09/17/2003 | EP1343891A2 Colon cancer marker |
| 09/17/2003 | EP1343824A1 Method for immobilising biomolecules, functionalised carrier material, and the use thereof |
| 09/17/2003 | EP1343811A1 Methods for preparing purified lipopeptides |
| 09/17/2003 | EP1343808A2 Process for the synthesis of a peptide having a trp residue |
| 09/17/2003 | EP1343516A2 Analogues of thiocoraline and be-22179 |
| 09/17/2003 | EP1343391A1 Method for modifying the protein structure of prions prp?sc in a targeted manner |
| 09/17/2003 | EP1230260B1 Hcv ns3 protease inhibitors |
| 09/17/2003 | EP1159295B1 Method of purifying whey of lactic acid fermentation by electrodialysis |
| 09/17/2003 | EP0858463B1 Alcohol-free wet extraction of gluten dough into gliadin and glutenin |
| 09/17/2003 | EP0571613B1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 09/17/2003 | CN1443197A Acid-modified arabinogalactan protein composition |
| 09/17/2003 | CN1443195A LHRH-antagonists, production and use thereof as medicament |
| 09/17/2003 | CN1443194A Methods for refolding proteins containing free cysteine residues |
| 09/17/2003 | CN1121614C Automated molecular biological diagnostic system |
| 09/17/2003 | CN1121410C Process for preparation of N-methyl-D-phenylalanyl-N-[1-[3-[ (aminoiminomethyl)-amino]propyl]-3,3-difluoro-2-oxohexyl]-L-prolinamide |
| 09/16/2003 | US6622094 Method for determining relative energies of two or more different molecules |
| 09/16/2003 | US6620918 Isolation of preferential particles from solution; apply sample solution to exchange resin, elute and recover preferential particle from exchange resin |
| 09/16/2003 | US6620917 Mixing polypeptide with a organic acid, incubating and clarifying; hydrolysis; chromatography; use for light weight, high performance fiber, composite and medical applications; formic, acetic, propionic, butyric, valeric acids |
| 09/16/2003 | US6620910 Of given amino acid sequence; receptor agonists; increased metabolic stability; longer duration of action; use in treatment of non-insulin-dependent type II diabetes, obesity, and type I diabetes |
| 09/16/2003 | CA2250274C Method and apparatus for preparing an acellular red blood cell substitute |
| 09/16/2003 | CA2139233C Compounds useful as sweeteners, their preparation |